Logo: Unknown author Unknown author, Public domain, via Wikimedia Commons5
American manufacturing company
AMETEK, Inc. is an American multinational conglomerate and global designer and manufacturer of electronic instruments and electromechanical devices with headquarters in the United States and over 150 sites worldwide. The company was founded in 1930. The company's original name, American Machine and Metals, was changed to AMETEK in the early 1960s, reflecting its evolution from a provider of heavy machinery to a manufacturer of analytical instruments, precision components and specialty materials.3 Its revenue was $6.2 billion in 2022.1Wikipedia text CC BY-SA 4.0
AMETEK, Inc. is an American multinational conglomerate and global designer and manufacturer of electronic instruments and electromechanical devices with headquarters in the United States and over 150 sites worldwide.3
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Revenue1112131410$7.4B in 2025+43% since 2019Operating income1112131410$1.9B in 2025+62% since 2019Net income1112131410$1.5B in 2025+72% since 2019
Revenue1516$2.0B in Q2 FY2026+6% since Q1 FY2026Operating income1516$528.2M in Q2 FY2026+3% since Q1 FY2026Net income1516$406.9M in Q2 FY2026+2% since Q1 FY2026
Every line of the income statement as filed: the last 3 fiscal years, latest first.10
Period ending
2025-12-31
2024-12-31
2023-12-31
Net sales
$7.4B
$6.9B
$6.6B
Cost of sales
$4.7B
$4.5B
$4.2B
Selling, general and administrative
$757.1M
$696.9M
$677.0M
Total operating expenses
$5.5B
$5.2B
$4.9B
Operating income
$1.9B
$1.8B
$1.7B
Interest expense
-$81.3M
-$113.0M
-$81.8M
Other (expense) income, net
-$30.7M
-$5.1M
-$19.3M
Income before Income Taxes
$1.8B
$1.7B
$1.6B
Provision for income taxes
$318.2M
$285.4M
$293.2M
Net income
$1.5B
$1.4B
$1.3B
Basic earnings per share (in USD per share)
$6.42
$5.95
$5.70
Diluted earnings per share (in USD per share)
$6.40
$5.93
$5.67
Basic shares (in shares)
230.5M shares
231.3M shares
230.5M shares
Diluted shares (in shares)
231.3M shares
232.2M shares
231.5M shares
No quarter-by-quarter statement was filed.
Total assets1711121410$16.1B in 2025+63% since 2019Total liabilities171112131410$5.4B in 2025+15% since 2019Shareholders’ equity1112131410$10.6B in 2025+108% since 2019Cash171112131410$458.0M in 2025+17% since 2019Long-term debt171112131410$1.1B in 2025−53% since 2019
Total assets1516$16.6B in Q2 FY2026+3% since Q1 FY2025Total liabilities1516$5.3B in Q2 FY2026−2% since Q1 FY2025Shareholders’ equity1516$11.3B in Q2 FY2026+6% since Q1 FY2025Cash1516$495.4M in Q2 FY2026+8% since Q1 FY2025Long-term debt1516$1.1B in Q2 FY2026−2% since Q1 FY2025
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.10
Period ending
2025-12-31
2024-12-31
2023-12-31
Cash and cash equivalents
$458.0M
$374.0M
Receivables
$1.1B
$948.8M
Inventories, net
$1.1B
$1.0B
Other current assets
$336.2M
$258.5M
Total current assets
$3.0B
$2.6B
Property, plant and equipment, net
$855.2M
$818.6M
Right of use assets, net
$273.1M
$235.7M
Goodwill
$7.2B
$6.6B
$6.4B
Other intangibles, net
$4.1B
$3.9B
Investments and other assets
$620.2M
$502.8M
Total assets
$16.1B
$14.6B
$15.0B
Short-term borrowings and current portion of long-term debt, net
$1.2B
$654.3M
Accounts payable
$618.0M
$523.3M
Customer advanced payments
$396.2M
$363.6M
Income taxes payable
$82.7M
$84.4M
Accrued liabilities and other
$537.0M
$472.9M
Total current liabilities
$2.8B
$2.1B
Long-term debt, net
$1.1B
$1.4B
Deferred income taxes
$788.9M
$831.0M
Other long-term liabilities
$732.8M
$620.9M
Total liabilities
$5.4B
$5.0B
Preferred stock, $0.01 par value; authorized 5,000,000 shares; none issued
$0
$0
Common stock, $0.01 par value; authorized 800,000,000 shares; issued: 2025 270,471,745 shares; 2024 270,064,222 shares
Cash from operations1112131410$1.8B in 2025+62% since 2019Capital spending1112131410$130.2M in 2025+27% since 2019Free cash flow1112131410$1.7B in 2025+65% since 2019Dividends paid1112131410$285.3M in 2025+124% since 2019Share buybacks1112131410$434.0M in 2025+3540% since 2019
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.10
Period ending
2025-12-31
2024-12-31
2023-12-31
Net income
$1.5B
$1.4B
$1.3B
Depreciation and amortization
$422.8M
$382.9M
$337.6M
Deferred income taxes
-$70.7M
-$12.9M
-$91.9M
Share-based compensation expense
$47.8M
$47.9M
$46.2M
Gain on sale of facilities
-$91.0K
-$995.0K
-$120.0K
(Increase) decrease in receivables
-$55.2M
$53.5M
$8.5M
(Increase) decrease in inventories and other current assets
-$26.8M
$73.0M
$56.6M
(Decrease) increase in payables, accruals and income taxes
-$51.4M
-$18.5M
$10.4M
Increase (decrease) in other long-term liabilities
$72.8M
-$41.3M
$67.3M
Pension contributions
-$8.5M
-$8.7M
-$8.7M
Other, net
-$9.1M
-$22.1M
-$3.8M
Total operating activities
$1.8B
$1.8B
$1.7B
Additions to property, plant and equipment
-$130.2M
-$127.1M
-$136.2M
Purchases of businesses, net of cash acquired
-$933.2M
-$117.5M
-$2.2B
Proceeds from sale of facilities
$200.0K
$4.2M
$880.0K
Other, net
$520.0K
-$4.5M
-$3.2M
Total investing activities
-$1.1B
-$244.8M
-$2.4B
Net change in short-term borrowings
$521.3M
-$889.7M
$892.3M
Repayments of long-term borrowings
-$514.9M
-$300.0M
$0
Repurchases of common stock
-$434.0M
-$212.0M
-$7.8M
Cash dividends paid
-$285.3M
-$258.8M
-$230.3M
Proceeds from stock option exercises
$36.4M
$66.9M
$50.9M
Other, net
-$9.7M
-$8.8M
-$7.7M
Total financing activities
-$686.3M
-$1.6B
$697.3M
Effect of exchange rate changes on cash and cash equivalents
Ametek sits at the top of its group. 253 entities, 39 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
AMETEK Advanced Industries, Inc. Subsidiary · Delaware, United States
AMETEK Aegis, Inc. Subsidiary · Delaware, United States
AMETEK Aerospace & Power Holdings, Inc. Subsidiary · Delaware, United States
and 227 more
Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; subsidiaries, stakes and holdings from Wikidata (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What Ametek reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
At December 31, 2025, the Company conducted business from office and operating facilities at owned and leased locations throughout the United States and select global markets. The Company leases a facility in Berwyn, Pennsylvania for its corporate headquarters.
The Company believes that all facilities have been adequately maintained, are in good operating condition, and are suitable for our current needs.
Rugged embedded electronics used in various industries.
Aerospace & Defense
Engine and avionics. Other aviation products and components.
Read the full text
Creaform
Creaform manufactures metrology and 3D engineering devices for use in shop-floor environments It is based in Lévis, Quebec, Canada. The company was founded in 2002 by Martin Lamontagne and two co-workers at Modelex. It began with a $200,000 loan from the Business Development Bank of Canada. In 2009, the company sold its 1000th laser scanner, priced from $50 –100,000. Creaform was acquired by Ametek in 2013 for $120 million in cash. At the time, Creaform had annual sales of $52 million. In 2017, Creaform opened a new, $20 million, headquarters in Levis. The 76,000 square foot headquarters is double the size of the old one, allowing Creaform to triple its production.
Heavy Vehicle and OEM
Motors, blowers, pumps, and other parts for heavy trucks and vehicles.
Materials Analysis and Imaging
Includes imaging products used in TV and movie production and tools such as Ion Mass spectrometers, electron Probe Microanalysis, Low-energy electron induced X-ray emission spectrometry, and atom Probe tomography.
Rauland
Healthcare (hospitals) and Education (schools) communication systems.
Oil & Gas / Power
Products for use in refineries and labs. Includes process analyzers, fuel analyzers, sample conditioning and heated and jacketed tubing.
Oct 31, 2024Reported quarterly or annual results75
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
460 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 48 major events, 314 insider forms, 8 large holders, 70 other. The latest 20:
77 open-market trades by officers, directors and large owners since October 2021: 1 buys and 76 sales. Grants, option exercises and gifts are left out.
BlackRockSC 13G/A, 3 filings Feb 1, 2022 to Jan 26, 202478
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
From the cover page of the 10-K filed Feb 17, 2026 (Section 12(b) of the Exchange Act).18
Risk factors and legal proceedings
The risks Ametek names in Item 1A of its 10-K filed Feb 17, 2026: 18 risks under these headings, as written.18
Risks Related to Our Operations
Our growth could suffer if the markets into which we sell our products and services decline, do not grow as anticipated, experience cyclicality, or a general downturn in the economy could adversely affect our business.
We may not properly execute, or realize anticipated cost savings or benefits from, our Operational Excellence initiatives.
Foreign and domestic economic, political, legal, compliance and business factors could negatively affect our international sales and operations.
Our international sales and operations may be adversely impacted by compliance with export laws.
Our reputation, ability to do business and financial statements may be impaired by improper conduct by any of our employees, agents or business partners.
Any inability to hire, train and retain a sufficient number of skilled officers and other employees could impede our ability to compete successfully.
If we are unable to develop new products on a timely basis, it could adversely affect our business and prospects.
Our technology is important to our success and our failure to protect this technology could put us at a competitive disadvantage.
A disruption in, shortage of, or price increases for, supply of our components and raw materials may adversely impact our operations.
We are subject to numerous governmental regulations, which may be burdensome or lead to significant costs.
We operate in highly competitive industries, which may adversely affect our results of operations or ability to expand our business.
The other 7 risks
Our business and financial performance could be adversely impacted by a significant disruption in, or breach in security of, our information technology systems.
Risks Related to Our Acquisitions
Our growth strategy includes strategic acquisitions. We may not be able to consummate future acquisitions or successfully integrate recent and future acquisitions.
The indemnification provisions of acquisition agreements by which we have acquired companies may not fully protect us and as a result we may face unexpected liabilities.
Risks Related to Our Financial Condition
Certain environmental risks may cause us to be liable for costs associated with hazardous or toxic substance clean-up which may adversely affect our financial condition.
We are subject to a variety of litigation and other legal and regulatory proceedings in the course of our business that could adversely affect our financial statements.
Restrictions contained in our revolving credit facility and other debt agreements may limit our ability to incur additional indebtedness.
Our goodwill and other intangible assets represent a substantial proportion of our total assets and the impairment of such substantial goodwill and intangible assets could have a negative impact on our financial condition and results of operations.
Legal proceedings
Please refer to Note 13 to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for information regarding certain litigation matters.
The Company is subject to a variety of litigation and other legal and regulatory proceedings incidental to its business (or the business operations of previously owned entities), including claims for damages arising out of the use of the Company’s products or services and claims relating to intellectual property matters, employment matters, tax matters, commercial disputes, competition and sales and trading practices, environmental matters, personal injury, insurance coverage and acquisition-related matters, as well as regulatory investigations or enforcement. Based upon the Company’s experience, the Company does not believe that these proceedings and claims will have a material adverse effect on its results of operations, financial position or cash flows.